IASIC Speaker Series is pleased to invite you to join us for an insightful webinar, Not All Kids Are Alright: Pediatric and Youth Emergency Visits and Hospitalizations after Cannabis Legalization, featuring groundbreaking research from...
Background and aims
Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how...
Source:
Cai, M., Choi, T., Xie, Y., & Al-Aly, Z. (2026). Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: Cohort study. BMJ, 392. doi: 10.1136/bmj-2025-086886.
The European Commission has introduced new controls on nine high-risk chemical precursors used in illicit drug production under Delegated Regulation (EU) 2026/314. Most of these substances are linked to synthetic cathinones, while one is...
This report highlights a growing concern around stimulant use and related harms in Canada, particularly involving cocaine and methamphetamine. Data from multiple national sources show that stimulant-related deaths have significantly...
The European Union Drugs Agency has released updated data sheets providing a clear and comparable overview of drug-related indicators across six Western Balkan partners under the Instrument for Pre-accession Assistance (IPA). These include...
Women with methamphetamine use disorder (MUD) in correctional settings often face complex challenges, including trauma histories, stigma, mental health difficulties, and limited access to evidence-based treatment. In Indonesia, structured...
Importance Cocaine use disorder is a serious public health problem and no medications have been proven effective for its treatment.
Objective To evaluate psilocybin in the treatment of cocaine use disorder. It was hypothesized...
Source:
Importance...
